Horizon Therapeutics Public Ltd Co Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Horizon Therapeutics Public Ltd Co quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Other Assets, Noncurrent for the quarter ending June 30, 2023 was $263M, a 63.8% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $263M +$102M +63.8% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $188M +$25.4M +15.6% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $204M +$63.4M +45% Dec 31, 2022 10-Q 2023-08-08
Q3 2022 $204M +$77.7M +61.7% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $161M +$28M +21.1% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $162M +$105M +184% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $141M +$85M +153% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $126M +$75.8M +151% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $133M +$91.7M +224% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $57.2M +$14.2M +33.2% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $55.7M +$7.39M +15.3% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $50.1M +$7.93M +18.8% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $40.9M -$2.88M -6.58% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $42.9M -$1.83M -4.09% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $48.3M +$39.4M +439% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $42.2M +$14.7M +53.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $43.8M +$14.5M +49.8% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $44.8M +$18M +67.2% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $8.96M -$27.1M -75.2% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $27.5M -$8.77M -24.2% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $29.2M -$621K -2.08% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $26.8M +$23.9M +842% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $36.1M +$33.7M +1424% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $36.2M +$30M +484% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 $29.8M +$23.7M +385% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $2.84M +$2.24M +374% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $2.37M +$2.15M +967% Dec 31, 2016 10-K 2018-02-28
Q3 2016 $6.2M -$3.31M -34.8% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $6.16M -$3.46M -36% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $600K -$9.99M -94.3% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $222K -$11.3M -98.1% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $9.51M -$6.02M -38.8% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $9.62M +$3.45M +56.1% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $10.6M +$4.09M +63% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $11.6M +$4.61M +66.2% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $15.5M +$12.1M +351% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $6.16M +$2.32M +60.5% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $6.5M +$2.32M +55.7% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $6.96M +$2.51M +56.4% Dec 31, 2013 10-K/A 2015-03-02
Q3 2013 $3.45M -$524K -13.2% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $3.84M -$240K -5.88% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $4.17M -$89K -2.09% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $4.45M +$3.9M +713% Dec 31, 2012 10-K 2014-03-13
Q3 2012 $3.97M +$3.42M +626% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $4.08M +$133K +3.37% Jun 30, 2012 10-Q 2012-08-10
Q1 2012 $4.26M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $547K -$2.93M -84.3% Dec 31, 2011 10-K 2013-03-18
Q3 2011 $547K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $3.95M Jun 30, 2011 10-Q 2011-09-02
Q4 2010 $3.47M Dec 31, 2010 10-K 2012-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.